This blend pairs CJC-1295 without DAC (Modified GRF 1-29, a short-acting GHRH analogue) with Ipamorelin (a selective GH-secretagogue-receptor agonist) in one lyophilised vial — a common combined reference preparation in GH-pathway research.
- Components: Mod GRF 1-29 + Ipamorelin
- Format: Lyophilised powder — 10 mg vials
- Verification: Batch-specific COA by Janoshik Analytical
Store at −20 °C, away from light and moisture.
Research use only. Not for human or veterinary consumption. Sold only to qualified researchers and institutions.
Research background: CJC-1295: What the Research Says, Ipamorelin: What the Research Says




